Follow
Ayaka Sugiura, PhD
Ayaka Sugiura, PhD
Verified email at vanderbilt.edu
Title
Cited by
Cited by
Year
Cell-programmed nutrient partitioning in the tumour microenvironment
BI Reinfeld, MZ Madden, MM Wolf, A Chytil, JE Bader, AR Patterson, ...
Nature 593 (7858), 282-288, 2021
5872021
Distinct regulation of Th17 and Th1 cell differentiation by glutaminase-dependent metabolism
MO Johnson, MM Wolf, MZ Madden, G Andrejeva, A Sugiura, ...
Cell 175 (7), 1780-1795. e19, 2018
5092018
Metabolic barriers to T cell function in tumors
A Sugiura, JC Rathmell
The Journal of Immunology 200 (2), 400-407, 2018
1822018
T cells specific for α-myosin drive immunotherapy-related myocarditis
ML Axelrod, WC Meijers, EM Screever, J Qin, MG Carroll, X Sun, ...
Nature 611 (7937), 818-826, 2022
1122022
A guide to interrogating immunometabolism
K Voss, HS Hong, JE Bader, A Sugiura, CA Lyssiotis, JC Rathmell
Nature Reviews Immunology 21 (10), 637-652, 2021
1062021
MTHFD2 is a metabolic checkpoint controlling effector and regulatory T cell fate and function
A Sugiura, G Andrejeva, K Voss, DR Heintzman, X Xu, MZ Madden, X Ye, ...
Immunity 55 (1), 65-81. e9, 2022
862022
Decreasing adrenergic or sympathetic hyperactivity after severe traumatic brain injury using propranolol and clonidine (DASH After TBI Study): study protocol for a randomized …
MB Patel, JW McKenna, JAM Alvarez, A Sugiura, JM Jenkins, ...
Trials 13, 1-10, 2012
772012
Elevated transferrin receptor impairs T cell metabolism and function in systemic lupus erythematosus
K Voss, AE Sewell, ES Krystofiak, KN Gibson-Corley, AC Young, ...
Science Immunology 8 (79), eabq0178, 2023
282023
Clinical features and multiplatform molecular analysis assist in understanding patient response to anti-PD-1/PD-L1 in renal cell carcinoma
E Shiuan, A Reddy, SO Dudzinski, AR Lim, A Sugiura, R Hongo, K Young, ...
Cancers 13 (6), 1475, 2021
122021
Therapeutic potential of DNA methyltransferase inhibitors with immune checkpoint inhibitor therapy in breast cancer
N Luo, A Sugiura, JM Balko
Cell Stress 2 (3), 69, 2018
102018
Cytotoxic T cells specific for alpha-myosin drive immunotherapy related myocarditis
J Balko, M Axelrod, W Meijers, E Screever, MG Carroll, X Sun, E Tannous, ...
22022
Acly Deficiency Enhances Myelopoiesis through Acetyl Coenzyme A and Metabolic–Epigenetic Cross-Talk
DL Greenwood, HE Ramsey, PTT Nguyen, AR Patterson, K Voss, ...
ImmunoHorizons 6 (12), 837-850, 2022
12022
Subset-specific mitochondrial and DNA damage shapes T cell responses to fever and inflammation
DR Heintzman, J Elasy, C Chi, X Ye, ES Krystoviak, W Khan, L Olson, ...
bioRxiv, 2022.11. 14.516478, 2022
12022
Androgen Signaling Restricts Glutaminolysis to Drive Sex-Specific Th17 Metabolism
NU Chowdhury, JY Cephus, MZ Madden, MM Wolf, C Chi, A Sugiura, ...
bioRxiv, 2023.02. 10.527741, 2023
2023
Functional Overlap of Inborn Errors of Immunity and Metabolism Genes Define T Cell Immunometabolic Vulnerabilities
AR Patterson, GA Needle, A Sugiura, C Chi, KLK Steiner, EL Fisher, ...
bioRxiv, 2023.01. 24.525419, 2023
2023
Identifying differential metabolic dependencies in CD4+ T cell subsets using targeted in vivo CRISPR/Cas9-based screening
A Sugiura
2022
Dysregulated Transferrin Receptor Disrupts T Cell Iron Homeostasis to Drive Inflammation in Systemic Lupus Erythematosus
K Voss, AC Young, KN Gibson-Corley, AE Sewell, ES Krystofiak, ...
bioRxiv, 2021.11. 25.470053, 2021
2021
805 Clonal, activated CD8+ T cells recognizing cardiac alpha-myosin drive immune checkpoint inhibitor associated myocarditis in mice
M Axelrod, W Meijers, E Tannous, X Sun, J Qin, A Sugiura, E Wescott, ...
Journal for ImmunoTherapy of Cancer 9 (Suppl 2), A842-A842, 2021
2021
Targeted CRISPR/Cas9-based in vitro and in vivo screening of metabolic pathways in primary T cells
A Sugiura, KL Beier, JC Rathmell
The Journal of Immunology 204 (1_Supplement), 86.33-86.33, 2020
2020
The system can't perform the operation now. Try again later.
Articles 1–19